|
|
A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus
David Durantel
,
Sandra Carrouée-Durantel
,
Bettina Werle-Lapostolle
,
Marie-Noëlle Brunelle
,
Christian Pichoud
,
et al.
Hepatology, 2004, 40 (4), pp.855-864
Journal articles
inserm-00137151v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
Stéphanie Villet
,
Aurélie Ollivet
,
Christian Pichoud
,
Luc Barraud
,
Jean-Pierre Villeneuve
,
et al.
Journal articles
inserm-00133115v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?
Fabien Zoulim
,
Maria Buti
,
Anna Lok
Journal articles
inserm-00193662v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.
Karine Lacombe
,
Anders Boyd
,
Joël Gozlan
,
Fabien Lavocat
,
Pierre-Marie Girard
,
et al.
Journal articles
inserm-00491989v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa
Anders Boyd
,
Sarah Maylin
,
Raoul Moh
,
Nadia Mahjoub
,
Delphine Gabillard
,
et al.
Journal articles
hal-01288716v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B
Margarita Papatheodoridi
,
Emilia Hadziyannis
,
Françoise Berby
,
Kalliopi Zachou
,
Barbara Testoni
,
et al.
Journal articles
hal-03932525v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies
Nathalie Isorce
,
Julie Lucifora
,
Fabien Zoulim
,
David Durantel
Journal articles
hal-03319419v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Early inhibition of hepatocyte innate responses by hepatitis B virus
Souphalone Luangsay
,
Marion Gruffaz
,
Nathalie Isorce
,
Barbara Testoni
,
Maud Michelet
,
et al.
Journal articles
hal-03315640v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biological basis for functional cure of chronic hepatitis B
Maria Martinez
,
Barbara Testoni
,
Fabien Zoulim
Journal articles
hal-03932283v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
Julie Lucifora
,
Marc Bonnin
,
Ludovic Aillot
,
Floriane Fusil
,
Sarah Maadadi
,
et al.
Journal articles
hal-01953649v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle
Thomas Lahlali
,
Jan Martin Berke
,
Karen Vergauwen
,
Adrien Foca
,
Koen Vandyck
,
et al.
Journal articles
hal-04165602v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
Thierry Poynard
,
Jean Marc Lacombe
,
Olivier Deckmyn
,
Valentina Peta
,
Sepideh Akhavan
,
et al.
Journal articles
hal-03266490v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sofosbuvir-Daclatasvir Is Suboptimal in Patients with Genotype 2 Chronic Hepatitis C Infection: Real-life Experience from the HEPATHER ANRS CO22 Cohort
Victor Lédinghen
,
Clovis Lusivika-Nzinga
,
Jean-Pierre Bronowicki
,
Fabien Zoulim
,
Dominique Larrey
,
et al.
Journal articles
hal-03704126v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Fabien Zoulim
,
Dominique Larrey
,
et al.
Journal articles
inserm-01057763v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
Christophe Hezode
,
Pascal Lebray
,
Victor de Ledinghen
,
Fabien Zoulim
,
Vincent Di Martino
,
et al.
Journal articles
hal-01784615v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
New anti-HCV agents in the pipeline
Fabien Zoulim
BMC Infectious Diseases, 2014, 14 (Suppl 2), pp.S15
Journal articles
inserm-00995744v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Victor Virlogeux
,
Fabien Zoulim
,
Pascal Pugliese
,
Isabelle Poizot-Martin
,
Marc-Antoine Valantin
,
et al.
Journal articles
inserm-01685739v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
How to improve access to therapy in hepatitis B patients
Miroslava Subic
,
Fabien Zoulim
Journal articles
hal-04165546v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Late hepatitis B reactivation following direct‐acting antiviral–based treatment of recurrent hepatitis C in an anti‐HBc–positive liver transplant recipient
Julien Vionnet
,
Manuel Pascual
,
Barbara Testoni
,
Christophe Combet
,
Sébastien Godat
,
et al.
Journal articles
hal-04165532v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
Paolo Angelo Cortesi
,
Raffaella Viganò
,
Sara Conti
,
Ilaria Lenci
,
Riccardo Volpes
,
et al.
Journal articles
hal-04165716v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Emerging drugs for hepatitis B.
Fabien Zoulim
Journal articles
inserm-00162225v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Matias Avila
,
Jean-François Dufour
,
Alexander Gerbes
,
Fabien Zoulim
,
Ramon Bataller
,
et al.
Journal articles
hal-03932559v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
Anna Lok
,
Fabien Zoulim
,
Geoffrey Dusheiko
,
Henry L.Y. Chan
,
Maria Buti
,
et al.
Journal articles
hal-03932571v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus\textendashHepatitis B Virus Co-infected Patients from Sub-Saharan Africa
Anders Boyd
,
Laura Houghtaling
,
Raoul Moh
,
Mariama Abdou Chekaraou
,
Delphine Gabillard
,
et al.
Journal articles
hal-03704124v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Inducers of NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro
Maud Michelet
,
Dulce Alfaiate
,
Brieux Chardès
,
Caroline Pons
,
Suzanne Faure-Dupuy
,
et al.
Journal articles
hal-03520759v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatitis B virus genetic variability and evolution.
Alan Kay
,
Fabien Zoulim
Journal articles
inserm-00133137v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine
Fabien Zoulim
,
Thierry Poynard
,
Françoise Degos
,
Alain Slama
,
Abdelkhader Al Hasnaoui
,
et al.
Journal of Viral Hepatitis, 2006, 13 (4), pp.278-288
Journal articles
inserm-00135954v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure
Marianne Maynard
,
Parviz Parvaz
,
Sandra Durantel
,
Michèle Chevallier
,
Philippe Chevallier
,
et al.
Journal of Hepatology, 2005, 42 (2), pp.279-81
Journal articles
inserm-00135957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.
Olivier Diaz
,
François Delers
,
Marianne Maynard
,
Sylvie Demignot
,
Fabien Zoulim
,
et al.
Journal articles
inserm-00139590v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection
Caroline Aspord
,
Juliana Bruder Costa
,
Marie-Christine Jacob
,
Tania Dufeu-Duchesne
,
Inga Bertucci
,
et al.
Journal articles
hal-01332410v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|